| Reproductive tract infections research | Lifetime | 10 | AU 1 | 99.73 |
| Syphilis Diagnosis and Treatment | Lifetime | 5 | AU 1 | 99.75 |
| Adolescent Sexual and Reproductive Health | Lifetime | 30 | AU 1 | 99.66 |
| Genital Health and Disease | Lifetime | 28 | AU 2 | 99.62 |
| Cervical Cancer and HPV Research | Lifetime | 68 | AU 2 | 99.55 |
| Sex work and related issues | Lifetime | 34 | AU 1 | 99.34 |
| HIV, Drug Use, Sexual Risk | Lifetime | 64 | AU 6 | 99.50 |
| HIV/AIDS Research and Interventions | Lifetime | 175 | AU 5 | 99.45 |
| Hepatitis B Virus Studies | Lifetime | 428 | AU 13 | 98.80 |
| HIV, TB, and STIs Epidemiology | Lifetime | 8 | AU 3 | 97.03 |
| Reproductive Health and Contraception | Lifetime | 143 | AU 5 | 97.71 |
| Colorectal and Anal Carcinomas | Lifetime | 418 | AU 11 | 97.42 |
| Urinary Tract Infections Management | Lifetime | 352 | AU 13 | 97.64 |
| Pelvic floor disorders treatments | Lifetime | 907 | AU 35 | 96.13 |
| Blood groups and transfusion | Lifetime | 829 | AU 19 | 95.69 |
| Sexuality, Behavior, and Technology | Lifetime | 411 | AU 31 | 95.16 |
| Sexual function and dysfunction studies | Lifetime | 638 | AU 15 | 94.52 |
| Bacterial Infections and Vaccines | Lifetime | 974 | AU 50 | 94.00 |
| HIV-related health complications and treatments | Lifetime | 814 | AU 20 | 94.55 |
| Female Genital Mutilation/Cutting Issues | Lifetime | 200 | AU 18 | 89.28 |
| Amoebic Infections and Treatments | Lifetime | 841 | AU 37 | 88.93 |
| Focus Groups and Qualitative Methods | Lifetime | 72 | AU 4 | 86.72 |
| COVID-19 Digital Contact Tracing | Lifetime | 338 | AU 22 | 61.83 |
| Reproductive tract infections research | 2021-2025 | 9 | AU 4 | 99.18 |
| Syphilis Diagnosis and Treatment | 2021-2025 | 6 | AU 3 | 98.86 |
| Adolescent Sexual and Reproductive Health | 2021-2025 | 37 | AU 8 | 98.74 |
| Sex work and related issues | 2021-2025 | 47 | AU 7 | 95.52 |
| Genital Health and Disease | 2021-2025 | 65 | AU 5 | 94.91 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 152 | AU 20 | 96.70 |
| Cervical Cancer and HPV Research | 2021-2025 | 234 | AU 8 | 94.84 |
| HIV/AIDS Research and Interventions | 2021-2025 | 543 | AU 31 | 94.95 |
| Herpesvirus Infections and Treatments | 2021-2025 | 354 | AU 7 | 87.55 |
| Urinary Tract Infections Management | 2021-2025 | 340 | AU 11 | 87.50 |
| Reproductive Health and Contraception | 2021-2025 | 399 | AU 30 | 83.40 |
| Poxvirus research and outbreaks | 2021-2025 | 366 | AU 9 | 80.41 |
| Blood groups and transfusion | 2021-2025 | 564 | AU 30 | 81.08 |
| Sexuality, Behavior, and Technology | 2021-2025 | 569 | AU 58 | 78.76 |
| Female Genital Mutilation/Cutting Issues | 2021-2025 | 154 | AU 9 | 71.53 |
| Bacterial Infections and Vaccines | 2021-2025 | 914 | AU 63 | 70.49 |
| HIV, TB, and STIs Epidemiology | 2021-2025 | 101 | AU 4 | 43.75 |
| Focus Groups and Qualitative Methods | 2021-2025 | 101 | AU 16 | 33.55 |
| Computational and Text Analysis Methods | 2021-2025 | 545 | AU 20 | 23.79 |
